{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T17:13:44Z","timestamp":1774199624993,"version":"3.50.1"},"reference-count":10,"publisher":"Japanese Society of Internal Medicine","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.7388","type":"journal-article","created":{"date-parts":[[2016,12,14]],"date-time":"2016-12-14T23:27:59Z","timestamp":1481758079000},"page":"3675-3678","source":"Crossref","is-referenced-by-count":14,"title":["Olmesartan-induced Enteropathy Manifesting as Wernicke-Korsakoff Syndrome"],"prefix":"10.2169","volume":"55","author":[{"given":"Takanori","family":"Uehara","sequence":"first","affiliation":[{"name":"Department of General Medicine, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatomi","family":"Ikusaka","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Ohira","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutaka","family":"Noda","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Shikino","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Kajiwara","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Ikegami","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Hirota","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Rubio-Tapia A, Herman ML, Ludvigsson JF, et al. Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc 87: 732-738, 2012.","DOI":"10.1016\/j.mayocp.2012.06.003"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Marthey L, Cadiot G, Seksik P, et al. Olmesartan-associated enteropathy: results of a national survey. Aliment Pharmacol Ther 40: 1103-1109, 2014.","DOI":"10.1111\/apt.12937"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Cyrany J, Vasatko T, Machac J, Nova M, Szanyi J, Kapacova M. Letter: telmisartan-associated enteropathy- is there any class effect? Aliment Pharmacol Ther 40: 569-570, 2014.","DOI":"10.1111\/apt.12850"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Herman ML, Rubio-Tapia A, Wu TT, Murray JA. A case of severe sprue-like enteropathy associated with valsartan. ACG Case Rep J 2: 92-94, 2015.","DOI":"10.14309\/crj.2015.15"},{"key":"5","unstructured":"5. Maier H, Hehemann K, Vieth M. Celiac disease-like enteropathy due to antihypertensive therapy with the angiotensin-II receptor type 1 inhibitor eprosartan. Cesk Patol 51: 87-88, 2015."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Reddy P, Mooradian AD. Clinical utility of anion gap in deciphering acid-base disorders. Int J Clin Pract 63: 1516-1525, 2009.","DOI":"10.1111\/j.1742-1241.2009.02000.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Dawson DJ, Sciberras CM, Whitwell H. Coeliac disease presenting with intenstinal pseudo-obstruction. Gut 25: 1003-1008, 1984.","DOI":"10.1136\/gut.25.9.1003"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Sechi G, Serra A. Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol 6: 442-455, 2007.","DOI":"10.1016\/S1474-4422(07)70104-7"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Fasano A, Catassi C. Clinical practice. Celiac disease. N Engl J Med 367: 2419-2426, 2012.","DOI":"10.1056\/NEJMcp1113994"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Basson M, Mezzarobba M, Weill A, et al. Severe intestinal malabsorption associated with olmesartan: a French nationwide observational cohort study. Gut, (in press).","DOI":"10.1136\/gutjnl-2015-309690"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/24\/55_55.7388\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T05:57:37Z","timestamp":1498370257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/24\/55_55.7388\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":10,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.7388","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}